Add-on therapy with saxagliptin 5 mg provided significant improvements from baseline to Week 24 in A1C and PPG compared with add-on placebo (Table 10)
[1] [2] 25 mg Speed of titration : Patients who increase their dose too rapidly or skip the recommended titration schedule experience more severe symptoms Individual susceptibility : Some patients are more prone to gastrointestinal side effects due to pre-existing conditions such as gastroparesis or functional dyspepsia Dietary habits : Consuming large, high-fat meals whilst on Ozempic can exacerbate nausea and vomiting Most patients who experience vomiting find that symptoms are most troublesome during the first 4-8 weeks of treatment or following dose escalation
Every GLP-1 treatment plan is physician-led, backed by nutrition and wellness support, and rooted in sustainable, whole-body health
Sleep disruption can become a part of daily life (studies indicate that postmenopausal women with insomnia have lower melatonin levels)
They will evaluate individual health factors, treatment goals, and potential risks, and recommend the most suitable plan for you
Considering these findings observed across a large, real-world cohort, the researchers concluded that avoidance of semaglutide based solely on concerns regarding the risk of NAION may not be warranted, as its potential benefits for blood glucose control and cardiovascular health likely outweigh its potential risks.
